SENNA- sennosides tablet 
Chain Drug Consortium, LLC (Premier Value)

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

DRUG FACTS

Active Ingredient (in each tablet)

Sennosides 8.6 mg

Purpose

Laxative

Uses

Warnings
Do not use

Ask a doctor before using if

you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel movements that continues over a period of 2 weeks.

Stop use and ask a doctor if

  • you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

 age

 starting dosage maximum dosage
 adults and children 12 years of age or older 2 tablets once a day 4 tablets twice a day
 children 6 to under 12 years 1 tablet once a day 2 tablets twice a day
 children 2 to under 6 years  1/2 tablet once a day 1 tablet twice a day
 children under 2 years ask a doctor ask a doctor


Other information


Inactive Ingredients

croscarmellose sodium, dibasic calcium phosphate dihydrate, dicalcium phosphate*, hypromellose, magnesium stearate, maltodextrin*, microcrystalline cellulose, mineral oil, polyethylene glycol*, purified water*, silicon dioxide*, stearic acid*, talc*, and triacetin*

*contains one or more of these ingredients

Questions or comments?

call toll free: 1-877-753-3935 Monday- Friday 9AM- 5PM EST

Principal Display Panel

**Compare to the active ingredient in senokot®

Senna

Sennosides 8.6 mg

Standardized senna concentrate

Natural vegetable laxative

Relieves occasional constipation

Distributed by:

CHAIN DRUG CONSORTIUM, LLC

3301 NW BOCA RATON BLVD. SUITE 101

BOCA RATON, FL 33431

KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION

Product Labeling

Premier Value Senna 8.6 mg

Sennosides 8.6 mg

SENNA 
sennosides tablet
Product Information
Product TypeHUMAN OTC DRUG LABELItem Code (Source)NDC:68016-117
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (SENNOSIDES) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM 
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE 
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS 
HYPROMELLOSES 
MAGNESIUM STEARATE 
MALTODEXTRIN 
CELLULOSE, MICROCRYSTALLINE 
MINERAL OIL 
POLYETHYLENE GLYCOLS 
WATER 
SILICON DIOXIDE 
STEARIC ACID 
TALC 
TRIACETIN 
Product Characteristics
ColorBROWN (BROWN) Scoreno score
ShapeROUND (ROUND) Size9mm
FlavorImprint Code S3;TLC080;S8
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68016-117-001 in 1 BOX
1100 in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart33404/18/2011
Labeler - Chain Drug Consortium, LLC (Premier Value) (101668460)

Revised: 10/2012
Document Id: 7048935f-40c4-4c9e-96e3-793453c8420d
Set id: 3f43ff4b-c6e5-42a6-b2da-dc5e862f2c76
Version: 2
Effective Time: 20121003
 
Chain Drug Consortium, LLC (Premier Value)